How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

21

HKG:2171
Get a brief AI stock analysisSaves ~ 15 minutes of your time

21

CARsgen Therapeutics Holdings LtdHKG 2171 Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XHKG - Hong Kong Exchange

FAIR VALUE

Is 2171 undervalued compared to its fair value?

The fair value of 2171 stock is hidden HKD. Relative to the market price of 4.41 HKD CARsgen Therapeutics Holdings Ltd is hidden.

CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently...[More about valuation]

CARsgen Therapeutics Holdings Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.338 $B

Price:

4.41 HKD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.728

FINANCIALS

CARsgen Therapeutics Holdings financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.37 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.4 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

2.6 B
2.2 B

Financial Position Analysis

Assets

2.6 B
Current Assets
2.2 B
Total non-current assets
0.43 B

Total current liabilities
0.33 B
Total non-current liabilities
0.11 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.14 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

CARsgen Therapeutics Holdings fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

CARsgen Therapeutics Rating

Is 2171 attractive for investment based on fundamental analysis?

2171 stock rating is hidden. CARsgen Therapeutics Holdings is a hidden by Eyestock methodology.

Get 2171 Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

2171.HK analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for 2171.HK to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

CARsgen Therapeutics Holdings Ltd dividends

2171.HK dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About 2171.HK stock

About the company CARsgen Therapeutics Holdings Ltd

Market cap $B

0.338

Dividend yield

Shares outstanding

572.776 B

CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 601 full-time employees. The company went IPO on 2021-06-18. The Company’s therapies are applied in the treatment of hematological malignancies and solid tumors. The firm have developed an upgraded B cell maturation antigen (BCMA) targeted CAR-T product, CT053, which is its sole core product candidate. The firm conducts its businesses in China and the United States.

2171.HK profile

  • Ticker

    2171.HK

  • Country

    China

  • Exchange

    XHKG - Hong Kong Exchange

  • Report currency

    CNY - Chinese yuan

  • IPO date

    18 June 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    601

  • City

    Shanghai

  • Address

    Building 12, No.388 Yindu Road, Xuhui District

  • Cusip

    G1996C100

2171.HK market tickers

OOTC - OTC

CRTHF

Frequently Asked Questions

What sector does CARsgen Therapeutics operate in?

CARsgen Therapeutics operates in Healthсare sector

What is market cap of CARsgen Therapeutics?

Market cap of CARsgen Therapeutics is 0.338 USD as of 24 Jul 2024

What is market price of one 2171 stock?

Market price of one 2171 stock is 4.41 HKD as of 24 Jul 2024

What is CARsgen Therapeutics revenue?

According to the recent report CARsgen Therapeutics revenue is —

What is CARsgen Therapeutics net income?

According to the recent report CARsgen Therapeutics net icnome is -404.472

What is CARsgen Therapeutics net income growh rate?

Net income growth rate of CARsgen Therapeutics is —